26 October 2011

GENETICS of PRIMARY ALDOSTERONISM Prof J.FUNDER AO MD FRCP FRACP

Sciencewww.sciencemag.org


Prev
Table of Contents
Next Science 11 February 2011:

Vol. 331 no. 6018 pp. 685-686

DOI: 10.1126/science.1202887

•Perspective

Medicine

The Genetics of Primary Aldosteronism

John W. Funder

+ Author Affiliations



Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria 3168, Australia.

E-mail: john.funder@princehenrys.org

Summary

Most people with consistently high blood pressure have “essential” hypertension, a physician's term for “no known cause.” Over the last 20 years, however, studies have shown that ∼1 in 10 patients do have an identifiable cause. Such patients overproduce the adrenal steroid hormone aldosterone (primary aldosteronism), which raises blood pressure and promotes sodium retention and potassium excretion. On page 768 of this issue, Choi et al. (1) report two different mutations in the gene encoding the potassium channel KCNJ5 in patients (8 of 22) with an aldosterone-producing adrenal adenoma (APA). A third mutation in the same gene is also identified in a father and two daughters with florid adrenal hyperplasia, a hereditary condition that is treated by removing the adrenals in early childhood. The findings have implications for understanding adrenal physiology and pathology.